24/7 Patient Assistance: 760-405-8205

Merry Tetef, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Merry Tetef graduated from the Harvard Medical School and completed her residency program at the UCLA Medical Center. She is specialized in Medical Oncology and board certified in Hematology and Oncology. Dr. Tetef has been in practice for more than 20 years and is affiliated with the Hoag Memorial Hospital Presbyterian and the Ronald Reagan UCLA Medical Center. During her career, she has also contributed to various publications of clinical interest.

  • Education & Training



    Medical School


    UCLA Medical Center


  • Board Certifications

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Hoag Memorial Hospital Presbyterian

    Languages: English/Spanish

    (949) 764–4624

    One Hoag Drive, P.O. Box 6100

    Newport Beach, California 92658

    Read More

    Ronald Reagan UCLA Medical Center

    Languages: English/Spanish

    (310) 825-9111

    757 Westwood Plaza

    Los Angeles, California 90095

    Read More

    St. Joseph Hospital

    Languages: English/Spanish

    (714) 633–9111

    1100 West Stewart Drive

    Orange, California 92868

    Read More
  • Publications & Memberships

    Dr. Merry Tetef has contributed to 3 publications.

    Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.

    Chew, H.K., Doroshow, J.H., Frankel, P., Margolin, K.A., Somlo, G., Lenz, H., Gordon, M., Zhang, W., Yang, D., Russell, C., Spicer, D., Synold, T., Bayer, R., Hantel, ...; J Clin Oncol. 2009 May 1.

    See more >>

    Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to t...

    Morgan, R. J., Newman, E. M., Doroshow, J. H., McGonigle, K., Margolin, K., Raschko, J., Chow, W., Somlo, G., Leong, L., Tetef, M., Shibata, S., Hamasaki, V., Carroll,...; Cancer Res. 1998 Jul 1.

    See more >>

    High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival.

    Somlo, G., Doroshow, J. H., Forman, S. J., Odom-Maryon, T., Lee, J., Chow, W., Hamasaki, V., Leong, L., Morgan, R., Margolin, K., Raschko, J., Shibata, S., Tetef, M., ...; J Clin Oncol. 1997 Aug.

    See more >>